BEUC's trilogue recommendations on the Pharma legislation

Europe faces serious challenges: growing shortages, high prices, and innovation that does not fully match patients’ real needs. The EU pharmaceutical legislation's revision comes at a decisive moment, alongside negotiations on the Critical Medicines Act. Both will shape future access to safe, available, and affordable medicines. This reform is a unique chance to improve access, strengthen trust in the regulatory system and healthcare systems’ resilience across Member States.  

This two-pager sets out BEUC’s 6 key recommendations for trilogue negotiations to secure real benefits for consumers and patients. For more information, see our key recommendations.